Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOSSOM trial of pregabalin and duloxetine in painful diabetic peripheral neuropathy
2017-004341-24Phase 4Completed
- Sponsor
- Krka
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pregabalin and duloxetine in diabetic polyneuropathy (DPN) (2 arms), sponsored by Krka. Primary endpoint: Clinically meaningful pain improvement after 12 weeks of pregabalin treatment. Started Jun 2019; status: completed.
02
Drugs
pregabalinduloxetine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2017-004341-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004341-24.